These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6390086)

  • 21. Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
    Meyer-Gerspach AC; Cajacob L; Riva D; Herzog R; Drewe J; Beglinger C; Wölnerhanssen BK
    PLoS One; 2016; 11(3):e0150803. PubMed ID: 26942445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of insulin secretion and insulin sensitivity between normal and impaired glucose tolerance subjects with normal fasting plasma glucose.
    Tang KT; Ho LT; Jap TS; Chang TC; Ching KN; Lam HC; Wu MS; Lee SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):73-8. PubMed ID: 2177367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycemic, hormone, and appetite responses to monosaccharide ingestion in patients with type 2 diabetes.
    Vozzo R; Baker B; Wittert GA; Wishart JM; Morris H; Horowitz M; Chapman I
    Metabolism; 2002 Aug; 51(8):949-57. PubMed ID: 12145765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.
    Seltzer HS; Allen EW; Herron AL; Brennan MT
    J Clin Invest; 1967 Mar; 46(3):323-35. PubMed ID: 6023769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic glucagon response to glucose in obesity with normal and impaired carbohydrate tolerance.
    Ratzmann KP; Schulz B; Witt S; Ziegler M
    Int J Obes; 1981; 5(2):163-9. PubMed ID: 7014481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application.
    Borghi VC; Wajchenberg BL; Albuquerque RH
    Clin Chim Acta; 1984 Jan; 136(1):39-48. PubMed ID: 6692564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.
    Larsson H; Berglund G; Ahrén B
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1778-82. PubMed ID: 7775622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
    Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
    Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
    Gossain VV; Sherma NK; Michelakis AM; Rovner DR
    Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation.
    Færch K; Vistisen D; Pacini G; Torekov SS; Johansen NB; Witte DR; Jonsson A; Pedersen O; Hansen T; Lauritzen T; Jørgensen ME; Ahrén B; Holst JJ
    Diabetes; 2016 Nov; 65(11):3473-3481. PubMed ID: 27504013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.